These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 30379780)

  • 21. Changes in psychiatric symptoms among persons with methamphetamine dependence predicts changes in severity of drug problems but not frequency of use.
    Polcin DL; Korcha R; Bond J; Galloway G; Nayak M
    Subst Abus; 2016; 37(1):209-14. PubMed ID: 25775225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
    Shearer J; Darke S; Rodgers C; Slade T; van Beek I; Lewis J; Brady D; McKetin R; Mattick RP; Wodak A
    Addiction; 2009 Feb; 104(2):224-33. PubMed ID: 19149817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
    McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
    Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychological Burden and Gender Differences in Methamphetamine-Dependent Individuals in Treatment.
    Simpson JL; Grant KM; Daly PM; Kelley SG; Carlo G; Bevins RA
    J Psychoactive Drugs; 2016; 48(4):261-9. PubMed ID: 27541988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment outcomes for methamphetamine users receiving outpatient counselling from the Stimulant Treatment Program in Australia.
    McKetin R; Dunlop AJ; Holland RM; Sutherland RA; Baker AL; Salmon AM; Hudson SL
    Drug Alcohol Rev; 2013 Jan; 32(1):80-7. PubMed ID: 22642414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health-related quality of life trajectories of methamphetamine-dependent individuals as a function of treatment completion and continued care over a 1-year period.
    Gonzales R; Ang A; Marinelli-Casey P; Glik DC; Iguchi MY; Rawson RA;
    J Subst Abuse Treat; 2009 Dec; 37(4):353-61. PubMed ID: 19553066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A qualitative study of methamphetamine initiation in Cape Town, South Africa.
    Hobkirk AL; Watt MH; Myers B; Skinner D; Meade CS
    Int J Drug Policy; 2016 Apr; 30():99-106. PubMed ID: 26614737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence.
    Alexander PD; Gicas KM; Willi TS; Kim CN; Boyeva V; Procyshyn RM; Smith GN; Thornton AE; Panenka WJ; Jones AA; Vila-Rodriguez F; Lang DJ; William MacEwan G; Honer WG; Barr AM
    Psychopharmacology (Berl); 2017 May; 234(9-10):1535-1547. PubMed ID: 28190084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impacts of COVID-19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia.
    Rathnayake K; Agius PA; Ward B; Hickman M; Maher L; Stoové M; Doyle JS; Hellard M; Wilkinson A; Quinn B; Crawford S; Sutton K; Dietze P
    Addiction; 2023 Aug; 118(8):1557-1568. PubMed ID: 36918365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence.
    Shoptaw S; Klausner JD; Reback CJ; Tierney S; Stansell J; Hare CB; Gibson S; Siever M; King WD; Kao U; Dang J
    BMC Public Health; 2006 Aug; 6():214. PubMed ID: 16919170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of treatment utilization and methamphetamine use during first 10 years after methamphetamine initiation.
    Brecht ML; Lovinger K; Herbeck DM; Urada D
    J Subst Abuse Treat; 2013; 44(5):548-56. PubMed ID: 23313146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.
    Rawson RA; Marinelli-Casey P; Anglin MD; Dickow A; Frazier Y; Gallagher C; Galloway GP; Herrell J; Huber A; McCann MJ; Obert J; Pennell S; Reiber C; Vandersloot D; Zweben J;
    Addiction; 2004 Jun; 99(6):708-17. PubMed ID: 15139869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Event-level relationship between methamphetamine use significantly associated with non-adherence to pharmacologic trial medications in event-level analyses.
    Hermanstyne KA; Santos GM; Vittinghoff E; Santos D; Colfax G; Coffin P
    Drug Alcohol Depend; 2014 Oct; 143():277-80. PubMed ID: 25156227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and Risk Factors of Emergency Department Presentations with Methamphetamine Intoxication or Dependence: A Systematic Review and Meta-analysis.
    Sibanda NC; Kornhaber R; Hunt GE; Morley K; Cleary M
    Issues Ment Health Nurs; 2019 Jul; 40(7):567-578. PubMed ID: 31025889
    [No Abstract]   [Full Text] [Related]  

  • 35. The contribution of methamphetamine use to crime: Evidence from Australian longitudinal data.
    McKetin R; Boden JM; Foulds JA; Najman JM; Ali R; Degenhardt L; Baker AL; Ross J; Farrell M; Weatherburn D
    Drug Alcohol Depend; 2020 Nov; 216():108262. PubMed ID: 32916517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studying Psychosocial Barriers to Drug Treatment Among Chinese Methamphetamine Users Using A 3-Step Latent Class Analysis.
    Wang J; Kelly BC; Liu T; Hao W
    J Subst Abuse Treat; 2016 Mar; 62():89-95. PubMed ID: 26738640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal methamphetamine's impact on frontline emergency services in Victoria, Australia.
    Jones R; Usher K; Woods C
    Australas Emerg Care; 2019 Dec; 22(4):201-205. PubMed ID: 31431391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between crystalline methamphetamine use and methamphetamine dependence.
    McKetin R; Kelly E; McLaren J
    Drug Alcohol Depend; 2006 Dec; 85(3):198-204. PubMed ID: 16723192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health service utilisation attributable to methamphetamine use in Australia: Patterns, predictors and national impact.
    McKetin R; Degenhardt L; Shanahan M; Baker AL; Lee NK; Lubman DI
    Drug Alcohol Rev; 2018 Feb; 37(2):196-204. PubMed ID: 28294443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
    McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
    Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.